Fennec Pharmaceuticals Statistics
Total Valuation
FENC has a market cap or net worth of $410.25 million. The enterprise value is $361.56 million.
| Market Cap | 410.25M |
| Enterprise Value | 361.56M |
Important Dates
The last earnings date was Thursday, November 12, 2026, before market open.
| Earnings Date | Nov 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
FENC has 35.31 million shares outstanding. The number of shares has increased by 28.15% in one year.
| Current Share Class | 35.31M |
| Shares Outstanding | 35.31M |
| Shares Change (YoY) | +28.15% |
| Shares Change (QoQ) | +4.52% |
| Owned by Insiders (%) | 2.96% |
| Owned by Institutions (%) | 28.60% |
| Float | 20.08M |
Valuation Ratios
The trailing PE ratio is 194.18 and the forward PE ratio is 14.03.
| PE Ratio | 194.18 |
| Forward PE | 14.03 |
| PS Ratio | 6.18 |
| Forward PS | 4.29 |
| PB Ratio | 8.32 |
| P/TBV Ratio | 8.34 |
| P/FCF Ratio | 130.28 |
| P/OCF Ratio | 130.28 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 94.63, with an EV/FCF ratio of 114.82.
| EV / Earnings | 178.37 |
| EV / Sales | 5.45 |
| EV / EBITDA | 94.63 |
| EV / EBIT | 97.25 |
| EV / FCF | 114.82 |
Financial Position
The company has a current ratio of 6.11, with zero debt.
| Current Ratio | 6.11 |
| Quick Ratio | 5.47 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 10.78 |
Financial Efficiency
Return on equity (ROE) is 9.07% and return on invested capital (ROIC) is 7.25%.
| Return on Equity (ROE) | 9.07% |
| Return on Assets (ROA) | 3.50% |
| Return on Invested Capital (ROIC) | 7.25% |
| Return on Capital Employed (ROCE) | 5.29% |
| Weighted Average Cost of Capital (WACC) | 10.90% |
| Revenue Per Employee | $1.90M |
| Profits Per Employee | $57,914 |
| Employee Count | 35 |
| Asset Turnover | 1.00 |
| Inventory Turnover | 1.69 |
Taxes
In the past 12 months, FENC has paid $480,000 in taxes.
| Income Tax | 480,000 |
| Effective Tax Rate | 19.15% |
Stock Price Statistics
The stock price has increased by +49.36% in the last 52 weeks. The beta is 1.21, so FENC's price volatility has been higher than the market average.
| Beta (5Y) | 1.21 |
| 52-Week Price Change | +49.36% |
| 50-Day Moving Average | 10.65 |
| 200-Day Moving Average | 9.35 |
| Relative Strength Index (RSI) | 61.12 |
| Average Volume (20 Days) | 171,620 |
Short Selling Information
The latest short interest is 454,453, so 1.29% of the outstanding shares have been sold short.
| Short Interest | 454,453 |
| Short Previous Month | 487,514 |
| Short % of Shares Out | 1.29% |
| Short % of Float | 2.26% |
| Short Ratio (days to cover) | 3.62 |
Income Statement
In the last 12 months, FENC had revenue of $66.37 million and earned $2.03 million in profits. Earnings per share was $0.06.
| Revenue | 66.37M |
| Gross Profit | 62.47M |
| Operating Income | 3.72M |
| Pretax Income | 2.51M |
| Net Income | 2.03M |
| EBITDA | 3.82M |
| EBIT | 3.72M |
| Earnings Per Share (EPS) | $0.06 |
Balance Sheet
The company has $48.68 million in cash and no debt, with a net cash position of $48.68 million or $1.38 per share.
| Cash & Cash Equivalents | 48.68M |
| Total Debt | n/a |
| Net Cash | 48.68M |
| Net Cash Per Share | $1.38 |
| Equity (Book Value) | 49.19M |
| Book Value Per Share | 1.40 |
| Working Capital | 67.71M |
Cash Flow
| Operating Cash Flow | 3.15M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 102,667 |
| Net Borrowing | -19.48M |
| Free Cash Flow | 3.15M |
| FCF Per Share | $0.09 |
Margins
Gross margin is 94.13%, with operating and profit margins of 5.60% and 3.05%.
| Gross Margin | 94.13% |
| Operating Margin | 5.60% |
| Pretax Margin | 3.78% |
| Profit Margin | 3.05% |
| EBITDA Margin | 5.76% |
| EBIT Margin | 5.60% |
| FCF Margin | 4.74% |
Dividends & Yields
FENC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -28.15% |
| Shareholder Yield | -28.15% |
| Earnings Yield | 0.51% |
| FCF Yield | 0.77% |
Analyst Forecast
The average price target for FENC is $17.20, which is 48.02% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $17.20 |
| Price Target Difference | 48.02% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (3Y) | 48.15% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
The last stock split was on September 5, 2014. It was a reverse split with a ratio of 1:3.
| Last Split Date | Sep 5, 2014 |
| Split Type | Reverse |
| Split Ratio | 1:3 |
Scores
FENC has an Altman Z-Score of 3.36 and a Piotroski F-Score of 7.
| Altman Z-Score | 3.36 |
| Piotroski F-Score | 7 |